111 related articles for article (PubMed ID: 1455913)
21. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
22. Vaccine protection against SIVmac infection by high- but not low-dose whole inactivated virus immunogen.
Hartung S; Norley SG; Ennen J; Cichutek K; Plesker R; Kurth R
J Acquir Immune Defic Syndr (1988); 1992; 5(5):461-8. PubMed ID: 1560342
[TBL] [Abstract][Full Text] [Related]
23. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus.
Cranage MP; Baskerville A; Ashworth LA; Dennis M; Cook N; Sharpe S; Farrar G; Rose J; Kitchin PA; Greenaway PJ
Lancet; 1992 Feb; 339(8788):273-4. PubMed ID: 1346285
[TBL] [Abstract][Full Text] [Related]
24. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
[TBL] [Abstract][Full Text] [Related]
25. Induction of humoral and cellular immunity to simian immunodeficiency virus: what are the requirements for protection?
Vaslin B; Le Grand R; Vogt G; Benveniste O; Gras G; Roques P; Stoeckel P; Salk PL; Salk J; Dormont D
Vaccine; 1994 Sep; 12(12):1132-40. PubMed ID: 7998424
[TBL] [Abstract][Full Text] [Related]
26. Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells.
Johnson PR; Montefiori DC; Goldstein S; Hamm TE; Zhou J; Kitov S; Haigwood NL; Misher L; London WT; Gerin JL
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1501-5. PubMed ID: 1466990
[No Abstract] [Full Text] [Related]
27. Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells.
Goldstein S; Elkins WR; London WT; Hahn A; Goeken R; Martin JE; Hirsch VM
J Med Primatol; 1994; 23(2-3):75-82. PubMed ID: 7966237
[TBL] [Abstract][Full Text] [Related]
28. SIV vaccine protection of rhesus monkeys.
Gardner MB; Carlson JR; Jennings M; Rosenthal A; Langlois A; Haynes B; Bolognesi D; Palker TJ
Biotechnol Ther; 1991; 2(1-2):9-19. PubMed ID: 1845125
[TBL] [Abstract][Full Text] [Related]
29. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
Meyer D; Anderson DE; Gardner MB; Torres JV
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
[TBL] [Abstract][Full Text] [Related]
30. Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. The European Concerted Action on 'Macaque Models for AIDS Research'.
Vaccine; 1995 Feb; 13(3):295-300. PubMed ID: 7631516
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.
Hu SL; Abrams K; Misher L; Stallard V; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR; Benveniste RE
J Med Primatol; 1992; 21(2-3):119-25. PubMed ID: 1433262
[TBL] [Abstract][Full Text] [Related]
32. Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural host.
Siegel F; Kurth R; Norley S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):217-26. PubMed ID: 7532099
[TBL] [Abstract][Full Text] [Related]
33. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
[TBL] [Abstract][Full Text] [Related]
34. Characterization of group specific antibodies in primates: studies with SIV envelope in macaques.
Haigwood NL; Misher L; Chin SM; Blair M; Planelles V; Scandella CJ; Steimer KS; Gardner MB; Yilma T; Hirsch VM
J Med Primatol; 1992; 21(2-3):82-90. PubMed ID: 1433271
[TBL] [Abstract][Full Text] [Related]
35. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus.
Ahmad S; Lohman B; Marthas M; Giavedoni L; el-Amad Z; Haigwood NL; Scandella CJ; Gardner MB; Luciw PA; Yilma T
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):195-204. PubMed ID: 8198872
[TBL] [Abstract][Full Text] [Related]
36. Induction of mucosal antibody responses by microsphere-encapsulated formalin-inactivated simian immunodeficiency virus in a male urethral challenge model.
Ishizaka ST; Israel ZR; Gettie A; Mishkin EM; Staas JK; Gilley RM; Dailey PJ; Montefiori DC; Marx PA; Eldridge JH
Vaccine; 1999 Jul; 17(22):2817-25. PubMed ID: 10438051
[TBL] [Abstract][Full Text] [Related]
37. Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells.
Putkonen P; Nilsson C; Hild K; Benthin R; Cranage M; Aubertin AM; Biberfeld G
J Med Primatol; 1993; 22(2-3):100-3. PubMed ID: 8411101
[TBL] [Abstract][Full Text] [Related]
38. In vitro spontaneous production of anti-SIV antibodies is a reliable tool in the follow-up of protection of SIV-vaccinated monkeys.
Zamarchi R; Veronese ML; Titti F; Geraci A; Verani P; Rossi GB; Amadori A; Chieco-Bianchi L
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1139-44. PubMed ID: 8312055
[TBL] [Abstract][Full Text] [Related]
39. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
[TBL] [Abstract][Full Text] [Related]
40. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine.
Hirsch VM; Goldstein S; Hynes NA; Elkins WR; London WT; Zack PM; Montefiori D; Johnson PR
J Infect Dis; 1994 Jul; 170(1):51-9. PubMed ID: 8014520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
